Japan Medical Dynamic Marketing, Inc.

As of March 31, 2026, Japan Medical Dynamic Marketing, Inc. carries a market capitalization of 74.84M, placing it among publicly traded companies globally. Its enterprise value stands at 90.06M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Japan Medical Dynamic Marketing, Inc.'s next confirmed earnings release is scheduled for November 4, 2026.

As of March 31, 2026, Japan Medical Dynamic Marketing, Inc. has 26.35M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Japan Medical Dynamic Marketing, Inc. maintains a current ratio of 3.23, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Japan Medical Dynamic Marketing, Inc.'s stock has gained approximately 17.48% over the past 52 weeks. The 50-day moving average sits at 3.70, while the 200-day moving average is 3.61.

As of March 31, 2026, Japan Medical Dynamic Marketing, Inc. holds 16.94M in cash and equivalents against 32.01M in total debt, resulting in a net debt position of 13.87M. Total book value stands at 138.47M, with working capital of 93.65M providing operational flexibility.

Japan Medical Dynamic Marketing, Inc.'s most recent stock split took place on May 28, 2002 with a 10:11 split ratio.